Group 1 - The company has nominated Chen Yan as a candidate for the independent director of its fourth board, and the nominee has agreed to this nomination [1] - The nomination was made after a thorough understanding of the nominee's professional background, education, qualifications, and any potential conflicts of interest [1] - The nominee has passed the qualification review by the company's third board nomination committee, confirming no close relationships that could affect independent performance [2] Group 2 - The nominee meets the qualifications and independence requirements set by relevant laws, regulations, and the Shenzhen Stock Exchange [2][3] - The nominee has participated in training and obtained relevant certification recognized by the stock exchange [2] - The nominee does not have any disqualifying conditions as per the Company Law of the People's Republic of China [2] Group 3 - The nominee has no significant business dealings with the company or its controlling shareholders [7] - The nominee has not been subject to any market entry bans by the China Securities Regulatory Commission [8] - The nominee has not received any public reprimands from the stock exchange in the last thirty-six months [8]
易明医药: 独立董事提名人声明与承诺-陈燕